ONCYNasdaq Canada
Market cap
$95.782 M
$0.80 +0.24%
Close of 7 Aug 2026
Revenue
—
Not reported
Earnings
-$28.8M
Loss-making
Shares outstanding
116,128,162
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for Oncolytics Biotech are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.